EUVIMEDEUVIMED entdecken
Crossref

Mettl14‐mediated m 6 A modification regulates the abnormal differentiation of small intestinal epithelial stem cells in diabetic state

Ti-Dong Shan iD, Yue Han, Ming-Quan Song, Li Chen

Journal of Cellular Physiology · 2023

DOI: 10.1002/jcp.31090 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cellular Physiology, 2023. Verfasst von Ti-Dong Shan und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, P. R. China. Hauptthemen laut MEDLINE: Cell Differentiation, Methyltransferases, Stem Cells, Epithelial Cells. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 27 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diabetes mellitus (DM) and its related complications are a global epidemic characterized by high morbidity and mortality. However, little is known about diabetic enteropathy (DE) and its the potential underlying mechanism. Intestinal epithelial stem cells (IESCs) were harvested from experimental mice, and the levels of dominant N6‐methyladenosine (m 6 A)‐related enzyme were detected by RT‐PCR, Western blotting, immunohistochemistry. The role of Mettl14 in the abnormal differentiation of intestinal epithelial cells (IECs) during DM was confirmed by knockdown experiments. RT‐PCR, MeRIP, and bioinformatics analysis were carried out to confirm the downstream target of Mettl14. Through bioinformatics analysis, RT‐PCR, and Western blotting, we further analyzed the differentiation‐related gene in the IECs from mice with DM. In this study, the levels of Mettl14 and m 6 A were higher in db/db mice than that in control mice. And abnormal differentiation of IECs in DM was associated with Mettl14 overexpression. Additionally, Mettl14 is a major determinant of IESCs identity and organoid‐forming upon DM state. Mechanistically, we revealed that the candidate binding target of Mettl14 was Fzd2 mRNA and affected Fzd2 stability. Moreover, Mettl14 downregulation was observed to attenuate the abnormal differentiation of IECs through modulating Fzd2 m6A modification in DM state. Together, our results provide definitive evidence for the essential role of Mettl14 in differentiation of IESCs in DM state.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cell DifferentiationMethyltransferasesStem CellsEpithelial CellsIntestinal MucosaAdenosineIntestine, SmallDiabetes Mellitus, ExperimentalAnimalsMiceMaleHumansMice, Inbred C57BL

Stichwörter der Autor:innen

Mettl14diabetes mellitusdifferentiationintestinal epithelial stem cell

Substanzen

MethyltransferasesN-methyladenosineMettl14 protein, mouseAdenosine

Autor:innen und Institutionen

  • Department of Gastroenterology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, P. R. China.

ORCID-Profile: Ti-Dong Shan

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Shan, T. D., Han, Y., Song, M. Q., & Chen, L. (2023). Mettl14‐mediated m 6 A modification regulates the abnormal differentiation of small intestinal epithelial stem cells in diabetic state. Journal of Cellular Physiology. https://doi.org/10.1002/jcp.31090

Vancouver

Shan TD, Han Y, Song MQ, Chen L. Mettl14‐mediated m 6 A modification regulates the abnormal differentiation of small intestinal epithelial stem cells in diabetic state. Journal of Cellular Physiology. 2023. doi:10.1002/jcp.31090

BibTeX
@article{Shan2023,
  author = {Shan, Ti-Dong and Han, Yue and Song, Ming-Quan and Chen, Li},
  title = {Mettl14‐mediated m 6 A modification regulates the abnormal differentiation of small intestinal epithelial stem cells in diabetic state},
  journal = {Journal of Cellular Physiology},
  year = {2023},
  doi = {10.1002/jcp.31090}
}
Kostenlos starten →